Cargando…
Therapeutic plasma exchange for the treatment of refractory necrotizing autoimmune myopathy
INTRODUCTION: Necrotizing autoimmune myopathy (NAM) is strongly associated with pathognomonic autoantibodies targeting 3‐hydroxy‐3‐methylglutaryl‐coenzyme A reductase (HMGCR) or signal recognition particle (SRP), whose levels in turn are correlated with serum creatine kinase (CK) and necrosis. Thus,...
Autores principales: | Kruse, Robert L., Albayda, Jemima, Vozniak, Sonja O., Lawrence, Courtney E., Goel, Ruchika, Lokhandwala, Parvez M., Ness, Paul M., Tobian, Aaron A.R., Bloch, Evan M., Crowe, Elizabeth P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303676/ https://www.ncbi.nlm.nih.gov/pubmed/35119135 http://dx.doi.org/10.1002/jca.21968 |
Ejemplares similares
-
Diagnostic Value of Muscle Ultrasound for Myopathies and Myositis
por: Albayda, Jemima, et al.
Publicado: (2020) -
Blood transfusion trends in the United States: national inpatient sample, 2015 to 2018
por: Goel, Ruchika, et al.
Publicado: (2021) -
Promoting access to COVID-19 convalescent plasma in low- and middle-income countries
por: Bloch, Evan M., et al.
Publicado: (2021) -
Necrotizing autoimmune myopathy
por: Babu, Sachin Suresh, et al.
Publicado: (2016) -
Factors associated with refractory autoimmune necrotizing myopathy with anti-signal recognition particle antibodies
por: Zhao, Yawen, et al.
Publicado: (2020)